Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2152

1.

Venereology in India.

Nichol CS.

Indian J Dermatol Venereol. 1972 May-Jun;38(3):97-98. No abstract available.

PMID:
29144314
2.

The marketing plan and outcome indicators for recruiting and retaining parents in the HomeStyles randomized controlled trial.

Byrd-Bredbenner C, Delaney C, Martin-Biggers J, Koenings M, Quick V.

Trials. 2017 Nov 15;18(1):540. doi: 10.1186/s13063-017-2262-3.

3.

Correction to: Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study.

Laffey JG, Bellani G, Pham T, Fan E, Madotto F, Bajwa EK, Brochard L, Clarkson K, Esteban A, Gattinoni L, van Haren F, Heunks LM, Kurahashi K, Laake JH, Larsson A, McAuley DF, McNamee L, Nin N, Qiu H, Ranieri M, Rubenfeld GD, Thompson BT, Wrigge H, Slutsky AS, Pesenti A; LUNG SAFE Investigators; ESICM Trials Group.

Intensive Care Med. 2017 Nov 14. doi: 10.1007/s00134-017-4981-z. [Epub ahead of print]

PMID:
29138899
4.

Correction to: The Intensive Care Global Study on Severe Acute Respiratory Infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study.

Sakr Y, Ferrer R, Reinhart K, Beale R, Rhodes A, Moreno R, Timsit JF, Brochard L, Thompson BT, Rezende E, Chiche JD; IC-GLOSSARI Investigators and ESICM Trials Group.

Intensive Care Med. 2017 Nov 14. doi: 10.1007/s00134-017-4979-6. [Epub ahead of print]

PMID:
29138898
5.
6.

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, Peto R, Pritchard KI, Bergh J, Dowsett M, Hayes DF; EBCTCG.

N Engl J Med. 2017 Nov 9;377(19):1836-1846. doi: 10.1056/NEJMoa1701830.

PMID:
29117498
7.

Severity of Disease in Humanized Mice Infected with Ebola Virus or Reston Virus is Associated with Magnitude of Early Viral Replication in Liver.

Spengler JR, Saturday G, Lavender KJ, Martellaro C, Keck JG, Nichol ST, Spiropoulou CF, Feldmann H, Prescott J.

J Infect Dis. 2017 Oct 26. doi: 10.1093/infdis/jix562. [Epub ahead of print]

PMID:
29087482
8.

Promoting healthy home environments and lifestyles in families with preschool children: HomeStyles, a randomized controlled trial.

Byrd-Bredbenner C, Martin-Biggers J, Povis GA, Worobey J, Hongu N, Quick V.

Contemp Clin Trials. 2017 Oct 24. pii: S1551-7144(17)30332-4. doi: 10.1016/j.cct.2017.10.012. [Epub ahead of print]

PMID:
29079392
9.

Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities.

Lo A, Ayre G, Ma R, Hsu F, Akagami R, McKenzie M, Valev B, Gete E, Vallieres I, Nichol A.

Int J Radiat Oncol Biol Phys. 2017 Sep 18. pii: S0360-3016(17)33891-9. doi: 10.1016/j.ijrobp.2017.09.024. [Epub ahead of print]

PMID:
29066124
10.

Genome Sequences of Crimean-Congo Hemorrhagic Fever Virus Strains Isolated in South Africa, Namibia, and Turkey.

Zivcec M, Albarino CG, Guerrero LIW, Ksiazek TG, Nichol ST, Swanepoel R, Rollin PE, Spiropoulou CF.

Genome Announc. 2017 Oct 19;5(42). pii: e01060-17. doi: 10.1128/genomeA.01060-17.

11.

Rapid determination of ebolavirus infectivity in clinical samples using a novel reporter cell line.

Kainulainen MH, Nichol ST, Albariño CG, Spiropoulou CF.

J Infect Dis. 2017 Sep 23. doi: 10.1093/infdis/jix486. [Epub ahead of print]

PMID:
29029133
12.

Identification of 2'-deoxy-2'-fluorocytidine as a potent inhibitor of Crimean-Congo hemorrhagic fever virus replication using a recombinant fluorescent reporter virus.

Welch SR, Scholte FEM, Flint M, Chatterjee P, Nichol ST, Bergeron É, Spiropoulou CF.

Antiviral Res. 2017 Nov;147:91-99. doi: 10.1016/j.antiviral.2017.10.008. Epub 2017 Oct 9.

PMID:
29024765
13.

Notes from the Field: Multiple Cases of Seoul Virus Infection in a Household with Infected Pet Rats - Tennessee, December 2016-April 2017.

Fill MA, Mullins H, May AS, Henderson H, Brown SM, Chiang CF, Patel NR, Klena JD, de St Maurice A, Knust B, Nichol ST, Dunn JR, Schaffner W, Jones TF.

MMWR Morb Mortal Wkly Rep. 2017 Oct 13;66(40):1081-1082. doi: 10.15585/mmwr.mm6640a4. No abstract available.

14.

Cause and timing of death and sub-group differential effects of erythropoietin in the EPO-TBI study.

Skrifvars MB, French C, Bailey M, Presneill J, Nichol A, Little L, Duranteau J, Huet O, Haddad S, Arabi Y, McArthur C, Cooper DJ, Bellomo R.

J Neurotrauma. 2017 Oct 12. doi: 10.1089/neu.2017.5135. [Epub ahead of print]

PMID:
29020866
15.

Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.

Raabe VN, Kann G, Ribner BS, Morales A, Varkey JB, Mehta AK, Lyon GM, Vanairsdale S, Faber K, Becker S, Eickmann M, Strecker T, Brown S, Patel K, De Leuw P, Schuettfort G, Stephan C, Rabenau H, Klena JD, Rollin PE, McElroy A, Ströher U, Nichol S, Kraft CS, Wolf T; Emory Serious Communicable Diseases Unit.

Clin Infect Dis. 2017 Sep 1;65(5):855-859. doi: 10.1093/cid/cix406.

16.

Improving Outcomes After Out-of-Hospital Cardiac Arrest.

Valenzuela T, Harrell AJ, Nichol G.

JAMA Cardiol. 2017 Nov 1;2(11):1183-1184. doi: 10.1001/jamacardio.2017.3472. No abstract available.

PMID:
28979976
17.

Economic Burden of Illness among Persons with Hemophilia B from HUGS Vb: Examining the Association of Severity and Treatment Regimens with Costs and Annual Bleed Rates.

Chen CX, Baker JR, Nichol MB.

Value Health. 2017 Sep;20(8):1074-1082. doi: 10.1016/j.jval.2017.04.017. Epub 2017 Jun 17.

PMID:
28964439
18.

Talking to the people that really matter about their participation in pandemic clinical research: A qualitative study in four European countries.

Gobat NH, Gal M, Butler CC, Webb SAR, Francis NA, Stanton H, Anthierens S, Bastiaens H, Godycki-Ćwirko M, Kowalczyk A, Pons-Vigués M, Pujol-Ribera E, Berenguera A, Watkins A, Sukumar P, Moore RG, Hood K, Nichol A.

Health Expect. 2017 Sep 27. doi: 10.1111/hex.12634. [Epub ahead of print]

PMID:
28960624
19.

Age of Red Cells for Transfusion and Outcomes in Critically Ill Adults.

Cooper DJ, McQuilten ZK, Nichol A, Ady B, Aubron C, Bailey M, Bellomo R, Gantner D, Irving DO, Kaukonen KM, McArthur C, Murray L, Pettilä V, French C; TRANSFUSE Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group.

N Engl J Med. 2017 Nov 9;377(19):1858-1867. doi: 10.1056/NEJMoa1707572. Epub 2017 Sep 27.

PMID:
28952891
20.

Whole Blood-Based Multiplex Immunoassays for the Evaluation of Human Biomarker Responses to Emerging Viruses in Resource-Limited Regions.

Harmon JR, Nichol ST, Spiropoulou CF, McElroy AK.

Viral Immunol. 2017 Nov;30(9):671-674. doi: 10.1089/vim.2017.0088. Epub 2017 Sep 22.

PMID:
28937957

Supplemental Content

Loading ...
Support Center